Stay updated on Anti-MAP Therapy in Crohn's: Clinical Trial
Sign up to get notified when there's something new on the Anti-MAP Therapy in Crohn's: Clinical Trial page.

Latest updates to the Anti-MAP Therapy in Crohn's: Clinical Trial page
- Check5 days agoChange DetectedThe study record for the anti-MAP therapy trial in adult Crohn’s disease is available again, with its design, eligibility criteria, study locations, outcomes, and supporting documents.SummaryDifference93%

- Check12 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check26 days agoChange DetectedA banner announces the NIH website transition and says “Super Intelligence” will replace “Artificial Intelligence” across NIH content. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check40 days agoChange DetectedThe footer’s ClinicalTrials.gov revision changed from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check54 days agoChange Detected403 Forbidden page is now shown, replacing the study record content. Related sections such as sponsor, investigators, and location information have been removed from the page.SummaryDifference18%

- Check61 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0 on the page, reflecting a new version of the study record. This update is metadata and does not change the study content, eligibility criteria, outcomes, or locations.SummaryDifference0.0%

Stay in the know with updates to Anti-MAP Therapy in Crohn's: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-MAP Therapy in Crohn's: Clinical Trial page.